Zimmer Biomet Reports First Quarter 2017 Financial Results

Thursday, April 27, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

- Net sales of $1.98 billion for the first quarter represent an increase of 3.8% over the prior year period, and an increase of 4.5% on a constant currency basis

 ZIMMER BIOMET HOLDINGS, INC. 

 RECONCILIATION OF 2017 PROJECTED DILUTED EPS 

 AND PROJECTED ADJUSTED DILUTED EPS 

 (unaudited) 

Projected Year Ended December 31, 2017:

High

Low

Diluted EPS

$                      4.88

$            4.68

Inventory step-up and other inventory and manufacturing related

   charges, intangible asset amortization, special items and other expense 

5.80

5.94

Taxes on above items(1) and other certain tax adjustments

(2.08)

(2.12)

Adjusted Diluted EPS

$                      8.60

$            8.50

(1) The tax effect for the U.S. jurisdiction is estimated based on an effective rate considering federal and state taxes, as well as permanent items.  For jurisdictions outside the U.S., the tax effect is estimated based upon the statutory rates where the items are projected to be incurred.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook